Methods
Differentiation of SIRT1 knockdown P19 cells. SIRT1 knockdown P19 cells were constructed by transfection with a SIRT1 shRNA plasmid (Santa Cruz) using plasmid transfection reagents (Santa Cruz) according to the manufacturer's instruction. Shortly, P19 cells were seeded at approximately 2 x 10 5 per well in a six-well dish, grown to 50-70% confluency, and transfected with 1 μg of a SIRT1 shRNA plasmid for 24 h. Stably transfected P19 cells were selected by incubating with 8 μg/ml of puromycin (Sigma-Aldrich) for a minimum of 3 weeks.
SIRT1 knockdown P19 cells were seeded at a density of 10 5 cells/mL in 90 mm petri dishes under non-adherent culture conditions and allowed for aggregation for 3 days. The embryoid bodies were dissociated into single cells by treatment with 0.25% trypsin-EDTA solution. The cells were seeded in a tissue culture dish at a density of approximately 5 x 10 3 cells/mL in culture media. After incubation for 24 h, the culture media were replaced with RPMI 1640 supplemented with 2% FBS, 50 units/ml penicillin and 50 mg/ml streptomycin.
The culture media were replenished every 2 days. Cells were harvested and analyzed during differentiation.
Immunocytochemistry. The differentiated P19 cells were fixed for 20 min with 4% paraformaldehyde and 0.1% Triton X-100 in PBS and then washed with PBS. The fixed cells were incubated in blocking solutions (PBS containing 0.5% FBS) for 1 h at room temperature to reduce nonspecific adsorption of antibodies. The cells were treated with diluted primary antibodies in blocking solutions for 1 h at room temperature or overnight at 4 o C and then washed with PBS. The cells were treated with Alexa Fluor 488-conjugated secondary antibodies or biotin-labeled secondary antibodies followed by incubation with Cy3-conjugated streptavidin in blocking solutions for 1 h at room temperature. Antibodies against neuron-specific βIII-tubulin (Tuj1), neuron specific enolase, neurofilament 200, MAP2, Nkx2.5, MHC, GFAP and S100 were employed as primary antibodies (Table S1 ). Biotinconjugated goat anti-mouse IgG, goat anti-rabbit IgG, Alexa Fluor 488-conjugated goat antimouse IgG and goat anti-rabbit IgG were used as secondary antibodies. After staining, cells were washed with DPBS several times and imaged by using fluorescence microscopy (Nikon Eclipse Ti-U microscope). Western blot analysis. Proteins were separated by using 10% or 12% SDS-PAGE and washing with TBST, it was treated with diluted secondary antibodies in TBST for 1 h at room temperature. The treated membrane was visualized using the West-zol kit (iNtRON Biotechnology) in the G box chemi XT4 (Syngene). Antibodies against Tuj1, neuron specific enolase, GAP43, Nkx2.5, MHC, GFAP and S100 were used as primary antibodies (Table   S2 ). Peroxidase-conjugated goat anti-mouse IgG and goat anti-rabbit IgG were employed as secondary antibodies. Signaling pathway study. P19 cells were seeded at a density of 10 
S3

S4
Reverse transcription polymerase chain reaction (RT-PCR).
Total RNAs were isolated using easy-BLUE (iNtRON Biotechnology) from the differentiated P19 cells at various times and subjected to cDNA synthesis using oligo(dT) primer and power cDNA synthesis kit (iNtRON Biotechnology) according to the manufacturer's instruction. The resulting cDNAs were used to determine the expression levels of genes of interest by using RT-PCR with the
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Bio-Rad PCR system. The PCR primers shown in Table S3 were purchased from Bioneer (Korea). 
